Frontlight ResearchEarly access
Trial site
Medyczne Centrum Hetmańska Piotr Leszczyński
- 6running trials
- 9closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)5 trials
- Rheumatoid arthritis3 trials
- Ankylosing spondylitis2 trials
- Osteoarthritis2 trials
- Dermatomyositis and polymyositis (myositis)1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 38 trials
- Phase 24 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed9 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- UCB Biopharma SRL4 trials
- Amzell1 trial
- AstraZeneca AB1 trial
- Boehringer Ingelheim1 trial
- Bristol-Myers Squibb1 trial
- and 7 more
Running trials
Not yet recruiting
Completed
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)2 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
Completed
Completed
A clinical study of MK-6194 for the treatment of Systemic Lupus Erythematosus (SLE) (MK-6194-006)
Completed
A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026